The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

ASH Update on HCT for AML: Are We Starting to Refer AML Patients Earlier in CR1? Can PTCy Overcome HLA Barriers in Haplo-Identical HCT?

49 views
March 8, 2021
Comments 0
Login to view comments. Click here to Login